News
LAB+ opens second international call for start-ups and scientific projects
LAB+ Company Builder has launched a new international call for scientists with an original, disruptive, and innovative project with significant commercial potential. This is the second call since the creation of LAB+, which already boasts a portfolio of four companies: B4-RNA, Guska, LoCBio and Scaffold Biotech. Selected start-ups in this call...
World Creativity and Innovation Day
April 21 marks World Creativity and Innovation Day, created by the UN in 2017 to raise awareness of the role these aspects play in human development. How is creativity and innovation applied in science? How can we generateknowledge and transform it into something useful for society? LAB+ Company Builder promotes creativity and innovation in all...
LAB+ finances 4 Uruguayan scientific start-ups
LAB+ presented this Thursday the closing of its first round of capitalization and the first four start-ups that will be financed with this fund. Each will receive US$ 750,000 for a two-year term. The objective of LAB+ is to support scientists with disruptive ideas in medicine, biology and technology, aimed at improving the welfare of humans,...
IN THE MEDIA
Local
Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo
Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse
En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’
Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio
En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer
La Diaria – What do the first four start-ups of the LAB+ seek to develop?
Telemundo (Channel 12) – Scaffold Biotech: more efficient vaccines for animals
En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska
Subrayado (Channel 10) – LAB+ closed its first financing cycle
Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+
La Diaria – Conversations with the first four biotech start-ups funded by LAB+
El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups
Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups
Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA
Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups
El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?
Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative
Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies
International
Yale Podcasts – Interview with Gonzalo Moratorio, Guska’s founder
Tekios – LAB+ international call for scientific projects and start-ups
SwissInfo – LAB+ international call for scientific projects and start-ups
Latin American Post – LAB+ pioneers a new era of scientific start-ups in Uruguay and beyond.
Infobae – Closing of first round of financing for LAB+.
EFE – The Institut Pasteur de Montevideo presents LAB+, with four start-ups.
Investing – The Institut Pasteur de Montevideo launches the LAB+ iniciative.
ABC (Paraguay) – With four start-ups, the Institut Pasteur de Montevideo launches the LAB+.
Bloomberg – New Venture Capital Fund Eyes Latin American Science Start-ups.
Bloomberg online – New venture capital fund sets its sights on Latin American scientific start-ups.
Perfil – A new venture capital fund targets Latin American science.
iProUP – Support for startups: Ficus Capital, biotech fund, looks for unicorns in Latin America.
Yahoo Finances – Biotech fund seeks unicorns in LatAm.